Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions

Completed · Not applicable

Conditions studied: Essential Hypertension

In brief

The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablets under fasting conditions.

Key facts

Study ID

NCT01012687

Run by

Roxane Laboratories

People needed

48

Starts

2007-04-01

Expected to finish

2007-05-01

Last updated by the study team

2018-01-23

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening

You may not qualify if…

• Positive test for HIV, Hepatitis B, or Hepatitis C.
• Treatment with known enzyme altering drugs.
• History of allergic or adverse response to perindopril or any comparable or similar product.

Where it is running

• Novum Pharmaceutical Research Services — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.